| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/1097-0142(19931215)72:12<3599::AID-CNCR2820721209>3.0.CO;2-8 |
| P698 | PubMed publication ID | 8252474 |
| P2093 | author name string | Hayashi H | |
| Fukumoto M | |||
| Kawabata K | |||
| Manabe T | |||
| Imamura M | |||
| Morimoto H | |||
| Nio Y | |||
| Masai Y | |||
| Tsubono M | |||
| P2860 | cites work | Pancreatic carcinogenesis-enhancement by cholecystokinin in the hamster-nitrosamine model | Q42374570 |
| Trophic effects of cholecystokinin octapeptide on the pancreas of the Syrian hamster. | Q53566347 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cholecystokinin | Q60315441 |
| P304 | page(s) | 3599-3606 | |
| P577 | publication date | 1993-12-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Loxiglumide (CR1505), a cholecystokinin antagonist, specifically inhibits the growth of human pancreatic cancer lines xenografted into nude mice | |
| P478 | volume | 72 |
| Q58752931 | Cardiovascular stents: overview, evolution, and next generation |
| Q41207409 | Cholecystokinin receptor antagonist, loxiglumide, inhibits invasiveness of human pancreatic cancer cell lines |
| Q42823811 | Cholecystokinin receptors in human pancreatic cancer cell lines |
| Q78158063 | Cholecystokinin-A receptor messenger RNA expression in human pancreatic cancer |
| Q53447303 | Effects of high-fat diet and cholecystokinin receptor blockade on promotion of pancreatic ductal cell tumors in the hamster. |
| Q70879336 | Enhancement of biliary carcinogenesis in hamsters by cholecystokinin |
| Q36421669 | Expression of receptors for gut peptides in human pancreatic adenocarcinoma and tumour-free pancreas |
| Q40452708 | On the role of cholecystokinin in pancreatic cancer. |
Search more.